Fasinumab

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Fasinumab
Accession Number
DB12157
Type
Biotech
Groups
Investigational
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Description

Fasinumab has been used in trials studying the basic science and treatment of Sciatica, Back Pain, Low Back Pain, Osteoarthritis, Hip, and Abdominal Pain Upper, among others.

Protein chemical formula
Not Available
Protein average weight
Not Available
Sequences
Not Available
Synonyms
Not Available
External IDs
REGN475
Categories
Not Available
UNII
11T51Q3082
CAS number
1190239-42-9

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347911291
Wikipedia
Fasinumab

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedBasic ScienceHealthy Volunteers1
1CompletedTreatmentHealthy Volunteers1
1, 2CompletedTreatmentKnee Osteoarthritis (Knee OA)1
2CompletedTreatmentSciatica1
2Not Yet RecruitingTreatmentKnee Osteoarthritis (Knee OA) / Osteoarthritis, Hip1
2TerminatedTreatmentBack Pain1
2TerminatedTreatmentUpper Abdominal Pain1
2WithdrawnTreatmentOsteoarthritis (OA)1
2, 3CompletedTreatmentBack Pain Lower Back1
2, 3CompletedTreatmentKnee Osteoarthritis (Knee OA) / Osteoarthritis, Hip1
2, 3RecruitingTreatmentOsteoarthritis, Knee / Osteoarthritis, Hip1
3Active Not RecruitingTreatmentBack Pain Lower Back Chronic / Osteoarthritis (OA)1
3Active Not RecruitingTreatmentOsteoarthritis of the Knee or Hip1
3Not Yet RecruitingTreatmentKnee Osteoarthritis (Knee OA) / Osteoarthritis, Hip1
3RecruitingTreatmentKnee Osteoarthritis (Knee OA) / Osteoarthritis, Hip2

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Description
Not Available
Kingdom
Organic Compounds
Super Class
Organic Acids
Class
Carboxylic Acids and Derivatives
Sub Class
Amino Acids, Peptides, and Analogues
Direct Parent
Peptides
Alternative Parents
Not Available
Substituents
Not Available
Molecular Framework
Not Available
External Descriptors
Not Available

Drug created on October 20, 2016 15:29 / Updated on November 02, 2018 07:20